Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Thomas H Sharp

22PUBLICATIONS

74CO-AUTHORS

Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Formal methods for softwareCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (22)

Sort by Publication Date:

|Nov 13, 2025

Pyroglutamation of cell surface proteins CD47 and TRP1 by glutaminyl cyclase modulates therapeutic antibody binding.

Anneloes van der Plas-van Duijn, Levi M T Winkelman, Claire Lensen

|Jul 30, 2025

Modulation of immunoglobulin G oligomerization by variable domain glycans: A mechanism to regulate complement activation.

Roxane Biersteker, Leoni Abendstein, Sanne van de Bovenkamp

|Apr 08, 2025

Inducing Cancer Cell Killing Using DNA Nanostructure-Mediated Superclustering of Death Receptors.

Göktuğ Aba, Subinuer Abudukelimu, Margot de Winter

|Dec 20, 2024

Streamlining segmentation of cryo-electron tomography datasets with Ais.

Mart G F Last, Leoni Abendstein, Lenard M Voortman

|Sep 18, 2024

Germline variant affecting p53β isoforms predisposes to familial cancer.

Stephanie A Schubert, Dina Ruano, Sebastien M Joruiz

|Sep 06, 2024

Structural basis for surface activation of the classical complement cascade by the short pentraxin C-reactive protein.

Dylan P Noone, Marjolein M E Isendoorn, Sebastiaan M W R Hamers

Pageof 4

Frequent Collaborators

6 joint publications

Leoni Abendstein

5 joint publications

Abraham J Koster

4 joint publications

Leendert A Trouw

4 joint publications

Sebastiaan M W R Hamers

3 joint publications

Douwe J Dijkstra

3 joint publications

Alexander Kros

3 joint publications

Aimee L Boyle

2 joint publications

Roy Pattipeiluhu

2 joint publications

Paul W H I Parren

2 joint publications

Piet Gros

Frequent Collaborators

6 joint publications

Leoni Abendstein

5 joint publications

Abraham J Koster

4 joint publications

Leendert A Trouw

4 joint publications

Sebastiaan M W R Hamers

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on : Jul 05, 2018

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on : Jan 11, 2019

See more related videos

Top Related Videos

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Using X-ray Crystallography, Biophysics, and Functional Assays to Determine the Mechanisms Governing T-cell Receptor Recognition of Cancer Antigens

Published on : Feb 06, 2017

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Characterization of Glycoproteins with the Immunoglobulin Fold by X-Ray Crystallography and Biophysical Techniques

Published on : Jul 05, 2018

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Establishing Cell Lines Overexpressing DR3 to Assess the Apoptotic Response to Anti-mitotic Therapeutics

Published on : Jan 11, 2019

See more related videos